Paul Billings

Dr. Paul R. Billings is a distinguished American doctor, lecturer, researcher, professor, and consultant on genetic information. His research interests include the impact of genomic data on society, the integration of genomics with diagnostics in health and medical care, and individualized genomic medicine. He is the author of over 250 publications and has appeared on talk shows such as The Oprah Show and 60 Minutes. He is currently the CEO and Director of Biological Dynamics. Biography Dr. Billings is a board-certified internist and clinical geneticist known for his extensive expertise in genomics and molecular medicine that spans more than 40 years. Dr. Billings has served many notable organizations, including roles with the Scientific Advisory Board of the Food and Drug Administration and the Genomic Medicine Advisory Committee at the Department of Veterans Affairs. He also served as a member of the United States Department of Health and Human Services Secretary's advisory committee on Genetics, Health, and Society. He was formerly a director of the Personalized Medicine Coalition and a member of the IOM Genomics Roundtable, helping to make an impact on healthcare for broad populations. Dr. Billings is the CEO and Director at Biological Dynamics, a company dedicated to improving global health outcomes by identifying early stage disease through its proprietary exosome diagnostic technology. Its ExoVerita™ platform offers a simple and automated workflow to capture and analyze exosomes, powering advanced detection tests for some of the most challenging diseases. Biological Dynamics’ ExoVita™ assays utilize the ExoVerita platform to enable reliable surveillance and early cancer detection to help enhance and extend lives. Prior to his role as CEO at Biological Dynamics, Dr. Billings was the Chief Medical Officer at Natera, a leader in cell-free DNA testing. Prior to that, he completed an Executive-in-Residence program at the California Innovation Center of Johnson & Johnson, a consultant for Quest Diagnostics Inc., and served as the medical director of the IMPACT Cancer Care Program at Thermo Fisher Scientific (TFS). Dr. Billings also held key roles at MissionBio, Life Technologies Inc. (LIFE), and the Genomic Medicine Institute, located at El Camino Hospital, the largest community hospital in Silicon Valley.